# Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

> **NCT05177289** · NA · RECRUITING · sponsor: **Jessa Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Chemotherapy-induced Alopecia

## Interventions

- **DEVICE:** Theradome® LH80 pro
- **DEVICE:** Scalp cooling

## Key facts

- **NCT ID:** NCT05177289
- **Lead sponsor:** Jessa Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-28
- **Primary completion:** 2025-01
- **Final completion:** 2030-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177289, "Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05177289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*